Cargando…

Metabolomic Profiling for Histologically Fibrotic Stage in Chronic Drug-Induced Liver Injury

Background and aims: Chronic drug-induced liver injury (DILI) is a rare but under-researched adverse drug reaction–related disease, which is highly likely to progress into liver fibrosis and even cirrhosis. In this study, metabolomics was used to screen out characteristic metabolites related to the...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Xian, Zhou, Ming-Xi, Cheng, Cheng, Li, Shan-Shan, Gao, Yuan, Ma, Zhi-Tao, Song, Xin-Hua, Bai, Zhao-Fang, Zou, Zheng-Sheng, Xiao, Xiao-He, Wang, Jia-Bo, Lu, Ya-Wen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163384/ https://www.ncbi.nlm.nih.gov/pubmed/35668948 http://dx.doi.org/10.3389/fphar.2022.896198

Ejemplares similares

Screening for Susceptibility-Related Biomarkers of Diclofenac-Induced Liver Injury in Rats Using Metabolomics
por: Tu, Can, et al.
Publicado: (2021)

Screening for biomarkers of liver injury induced by Polygonum multiflorum: a targeted metabolomic study
por: Dong, Qin, et al.
Publicado: (2015)

Metabolomic Study on Idiosyncratic Liver Injury Induced by Different Extracts of Polygonum multiflorum in Rats Integrated with Pattern Recognition and Enriched Pathways Analysis
por: Li, Chun-Yu, et al.
Publicado: (2016)

Herb-Induced Liver Injury Related to Reynoutria multiflora (Thunb.) Moldenke: Risk Factors, Molecular and Mechanistic Specifics
por: Zhai, Xing-Ran, et al.
Publicado: (2021)

Untargeted Metabolomics Reveals Dose-Response Characteristics for Effect of Rhubarb in a Rat Model of Cholestasis
por: Zhang, Cong-En, et al.
Publicado: (2016)

Investigation of Liver Injury of Polygonum multiflorum Thunb. in Rats by Metabolomics and Traditional Approaches
por: Li, Yun-Xia, et al.
Publicado: (2017)

Electronic Cigarette Exposure Enhances Lung Inflammatory and Fibrotic Responses in COPD Mice
por: Han, Hongwei, et al.
Publicado: (2021)

Serum Metabolomic Analysis of Chronic Drug-Induced Liver Injury With or Without Cirrhosis
por: Chen, Shuai-shuai, et al.
Publicado: (2021)

Comprehensive metabolomics and lipidomics profiling uncovering neuroprotective effects of Ginkgo biloba L. leaf extract on Alzheimer’s disease
por: Liu, Li-Wei, et al.
Publicado: (2022)

Novel Anti-fibrotic Therapies
por: McVicker, Benita L., et al.
Publicado: (2017)

Integrated Plasma Metabolomics and Gut Microbiota Analysis: The Intervention Effect of Jiawei Xiaoyao San on Liver Depression and Spleen Deficiency Liver Cancer Rats
por: Li, Zhuoxian, et al.
Publicado: (2022)

Astragalus and its formulas as a therapeutic option for fibrotic diseases: Pharmacology and mechanisms
por: Zhu, Yi, et al.
Publicado: (2022)

Metabolomic Analysis Uncovers Lipid and Amino Acid Metabolism Disturbance During the Development of Ascites in Alcoholic Liver Disease
por: Cheng, Cheng, et al.
Publicado: (2022)

Metabolomic Signatures of Autoimmune Hepatitis in the Development of Cirrhosis
por: Li, Shan-shan, et al.
Publicado: (2021)

Are mast cells instrumental for fibrotic diseases?
por: Overed-Sayer, Catherine, et al.
Publicado: (2014)

Screening for Susceptibility-Related Factors and Biomarkers of Xianling Gubao Capsule-Induced Liver Injury
por: Li, Chun-yu, et al.
Publicado: (2020)

Inflammatory stress potentiates emodin-induced liver injury in rats
por: Tu, Can, et al.
Publicado: (2015)

Corrigendum: Inflammatory Stress Potentiates Emodin-Induced Liver Injury in Rats
por: Tu, Can, et al.
Publicado: (2021)

Metabolomics profiling to characterize cerebral ischemia-reperfusion injury in mice
por: Chen, Qiong, et al.
Publicado: (2023)

The Interaction Between Pulmonary Fibrosis and COVID-19 and the Application of Related Anti-Fibrotic Drugs
por: Shen, Hao, et al.
Publicado: (2022)

Anti-fibrotic Potential of AT(2) Receptor Agonists
por: Wang, Yan, et al.
Publicado: (2017)

A review of herb-induced liver injury in mainland china
por: Yang, Yan, et al.
Publicado: (2022)

Metabolomics Profiles Associated with the Treatment of Zuojin Pill on Patients with Chronic Nonatrophic Gastritis
por: Ma, Xiao, et al.
Publicado: (2022)

Potential mechanisms of Lian-Zhi-Fan solution for TNBS-induced ulcerative colitis in rats via a metabolomics approach
por: Bai, Junyi, et al.
Publicado: (2022)

Metabolomics Profiling and Diagnosis Biomarkers Searching for Drug-Induced Liver Injury Implicated to Polygonum multiflorum: A Cross-Sectional Cohort Study
por: Huang, Ying, et al.
Publicado: (2020)

Plasma metabolomic and lipidomic alterations associated with anti-tuberculosis drug-induced liver injury
por: Wang, Ming-Gui, et al.
Publicado: (2022)

Metabolomic Analysis Uncovers Energy Supply Disturbance as an Underlying Mechanism of the Development of Alcohol‐Associated Liver Cirrhosis
por: Huang, Ying, et al.
Publicado: (2021)

Anaphylactoid reactions induced by Shuanghuanglian injection and Shenmai injection and metabolomics analysis
por: Zhang, Chi, et al.
Publicado: (2023)

Integration of Metabolomics and Transcriptomics Reveals the Therapeutic Mechanism Underlying Paeoniflorin for the Treatment of Allergic Asthma
por: Shou, Qiyang, et al.
Publicado: (2019)

Metabolomics profiles in acute-on-chronic liver failure: Unveiling pathogenesis and predicting progression
por: Liu, Guofeng, et al.
Publicado: (2022)

Susceptibility-Related Factor and Biomarkers of Dietary Supplement Polygonum multiflorum-Induced Liver Injury in Rats
por: Tu, Can, et al.
Publicado: (2019)

Untargeted and Targeted Metabolomics Reveal the Underlying Mechanism of Aspirin Eugenol Ester Ameliorating Rat Hyperlipidemia via Inhibiting FXR to Induce CYP7A1
por: Xiao-Rong, Lu, et al.
Publicado: (2021)

Screening of Biomarkers and Toxicity Mechanisms of Rifampicin-Induced Liver Injury Based on Targeted Bile Acid Metabolomics
por: Deng, Yang, et al.
Publicado: (2022)

Study on the mechanism of acute liver injury protection in Rhubarb anthraquinone by metabolomics based on UPLC-Q-TOF-MS
por: Gong, Xiaohong, et al.
Publicado: (2023)

Fibrocytes in the fibrotic lung: altered phenotype detected by flow cytometry
por: Reese, Charles, et al.
Publicado: (2014)

Hepatoprotective and Anti-fibrotic Agents: It's Time to Take the Next Step
por: Weiskirchen, Ralf
Publicado: (2016)

A Clinical Perspective of Anti-Fibrotic Therapies for Cardiovascular Disease
por: Fang, Lu, et al.
Publicado: (2017)

Therapeutic Targeting of Fibrotic Epithelial-Mesenchymal Transition–An Outstanding Challenge
por: Fintha, Attila, et al.
Publicado: (2019)

Mechanism of Paeoniflorin on ANIT-Induced Cholestatic Liver Injury Using Integrated Metabolomics and Network Pharmacology
por: Chen, Lisheng, et al.
Publicado: (2021)

Treatment of Rheumatoid Arthritis Using Combination of Methotrexate and Tripterygium Glycosides Tablets—A Quantitative Plasma Pharmacochemical and Pseudotargeted Metabolomic Approach
por: Wang, Menglei, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_r1o6oqsid97gleugf3nacj373a